ICOCIMS
International student Congress of Clinical Innovation and Medical Sciences
Dr. Elisa Araldi, an accomplished researcher in Computational Systems Medicine, is currently an Assistant Professor in Biochemistry at the Department of Medicine and Surgery, University of Parma. She holds a degree in Cellular and Molecular Biology from the University of Pisa and the Scuola Normale Superiore of Pisa, and earned her Ph.D. in Pathobiology and Translational Medicine from New York University. With a research background spanning renowned institutions such as Harvard Medical School, New York University, Yale University, and ETH Zurich, Dr. Araldi is recognized for her groundbreaking work. She was recently honored with the Early Career Fellowship Programme by Human Technopole for her research on cholesterol biosynthesis intermediates (CBI) and their broader physiological impacts, reflecting her commitment to advancing scientific understanding and innovative interventions.
Dr. Elisa Araldi, an accomplished researcher in Computational Systems Medicine, is currently an Assistant Professor in Biochemistry at the Department of Medicine and Surgery, University of Parma. She holds a degree in Cellular and Molecular Biology from the University of Pisa and the Scuola Normale Superiore of Pisa, and earned her Ph.D. in Pathobiology and Translational Medicine from New York University. With a research background spanning renowned institutions such as Harvard Medical School, New York University, Yale University, and ETH Zurich, Dr. Araldi is recognized for her groundbreaking work. She was recently honored with the Early Career Fellowship Programme by Human Technopole for her research on cholesterol biosynthesis intermediates (CBI) and their broader physiological impacts, reflecting her commitment to advancing scientific understanding and innovative interventions.
Dr. Simona Colla, currently an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, completed her BSc and MSc degrees at the University of Parma. Her laboratory is actively engaged in investigating the complex mechanisms that underlie the pathogenesis and progression of multiple myeloma (MM) and myelodysplastic syndromes.
Dr. Simona Colla, currently an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, completed her BSc and MSc degrees at the University of Parma. Her laboratory is actively engaged in investigating the complex mechanisms that underlie the pathogenesis and progression of multiple myeloma (MM) and myelodysplastic syndromes.
Professor Falasca is presently serving as a Full Professor in Biochemistry at the Department of Medicine and Surgery, University of Parma. Previously, he held the position of Full Professor of Metabolism at Curtin Medical School, Curtin University, Perth, Australia, and also served as an Adjunct Professor in Molecular Pharmacology at the Blizard Institute, Queen Mary University of London. He has held positions as a Professor at Queen Mary University of London and as a Senior Lecturer in the Department of Medicine at University College London. He earned his PhD from the Mario Negri Institute in Italy and conducted postdoctoral studies at the Department of Pharmacology, New York University, USA. His primary research interest revolves around exploring cellular and intercellular communication, with a specific emphasis on studying the role of the endocannabinoid system in the progression of pancreatic cancer, gastrointestinal functions, and the pathophysiology of exosomes.
Professor Falasca is presently serving as a Full Professor in Biochemistry at the Department of Medicine and Surgery, University of Parma. Previously, he held the position of Full Professor of Metabolism at Curtin Medical School, Curtin University, Perth, Australia, and also served as an Adjunct Professor in Molecular Pharmacology at the Blizard Institute, Queen Mary University of London. He has held positions as a Professor at Queen Mary University of London and as a Senior Lecturer in the Department of Medicine at University College London. He earned his PhD from the Mario Negri Institute in Italy and conducted postdoctoral studies at the Department of Pharmacology, New York University, USA. His primary research interest revolves around exploring cellular and intercellular communication, with a specific emphasis on studying the role of the endocannabinoid system in the progression of pancreatic cancer, gastrointestinal functions, and the pathophysiology of exosomes.
Jaskirat Singh, BEng. Specialist of robotic and automated systems integrated with the new technologies of Industry 4.0.
He holds a bachelor degree in Automation and Mechatronic Systems from ITS Lombardia Meccatronica, and a bachelor degree in Industrial Engineering from St. Clements University.
Currently, he is pursuing a master's degree in International Studies, specializing in Advanced Manufacturing Engineering and Management.
Researcher in the field of kinematic simulation and new materials for 3D printers.
Participated in a research and development project, in collaboration with the Italian National Research Council (CNR), to develop an algorithm for predictive maintenance of a surgical robot.
Jaskirat Singh, BEng. Specialist of robotic and automated systems integrated with the new technologies of Industry 4.0.
He holds a bachelor degree in Automation and Mechatronic Systems from ITS Lombardia Meccatronica, and a bachelor degree in Industrial Engineering from St. Clements University.
Currently, he is pursuing a master's degree in International Studies, specializing in Advanced Manufacturing Engineering and Management.
Researcher in the field of kinematic simulation and new materials for 3D printers.
Participated in a research and development project, in collaboration with the Italian National Research Council (CNR), to develop an algorithm for predictive maintenance of a surgical robot.